Corteva Inc
NYSE:CTVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corteva Inc
NYSE:CTVA
|
US |
|
Jasper Therapeutics Inc
NASDAQ:JSPR
|
US |
|
Genoway SA
PAR:ALGEN
|
FR |
|
C
|
Clarus Corp
F:BDO
|
US |
|
Rieter Holding AG
SIX:RIEN
|
CH |
|
Zelira Therapeutics Ltd
ASX:ZLD
|
AU |
|
L
|
Lian Beng Group Ltd
SGX:L03
|
SG |
|
AKB Primor'ye PAO
MOEX:PRMB
|
RU |
|
P
|
Perak Transit Bhd
KLSE:PTRANS
|
MY |
|
Dexus
ASX:DXS
|
AU |
|
B Communications Ltd
OTC:BCOMF
|
IL |
|
Takada Corp
TSE:1966
|
JP |
|
Kinnate Biopharma Inc
F:6KB
|
US |
|
V
|
Vast Resources PLC
XBER:D9A
|
UK |
|
D
|
DVL Inc
OTC:DVLN
|
US |
Intrinsic Value
The
intrinsic value for
Corteva Inc (CTVA)
under the Base Case is
hidden
USD.
Compared with the current market price of 81.32 USD, the stock appears
hidden
.
CTVA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CTVA usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Corteva Inc.
The
intrinsic value for
Corteva Inc (CTVA)
under the Base Case is
hidden
USD.
Compared with the current market price of 81.32 USD, the stock appears hidden .